AU2020396557B2 - Protein-loaded PLGA nanospheres - Google Patents
Protein-loaded PLGA nanospheresInfo
- Publication number
- AU2020396557B2 AU2020396557B2 AU2020396557A AU2020396557A AU2020396557B2 AU 2020396557 B2 AU2020396557 B2 AU 2020396557B2 AU 2020396557 A AU2020396557 A AU 2020396557A AU 2020396557 A AU2020396557 A AU 2020396557A AU 2020396557 B2 AU2020396557 B2 AU 2020396557B2
- Authority
- AU
- Australia
- Prior art keywords
- nanosphere
- serum albumin
- protein
- plga
- nanospheres
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/429—Thiazoles condensed with heterocyclic ring systems
- A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
- A61K31/7036—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin having at least one amino group directly attached to the carbocyclic ring, e.g. streptomycin, gentamycin, amikacin, validamycin, fortimicins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/20—Interleukins [IL]
- A61K38/208—IL-12
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5107—Excipients; Inactive ingredients
- A61K9/513—Organic macromolecular compounds; Dendrimers
- A61K9/5146—Organic macromolecular compounds; Dendrimers obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyamines, polyanhydrides
- A61K9/5153—Polyesters, e.g. poly(lactide-co-glycolide)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5192—Processes
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biomedical Technology (AREA)
- Optics & Photonics (AREA)
- Nanotechnology (AREA)
- Physics & Mathematics (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962944191P | 2019-12-05 | 2019-12-05 | |
| US62/944,191 | 2019-12-05 | ||
| PCT/US2020/063314 WO2021113638A1 (en) | 2019-12-05 | 2020-12-04 | Protein-loaded plga nanospheres |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2026216794 Division | 2020-12-04 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU2020396557A1 AU2020396557A1 (en) | 2022-06-23 |
| AU2020396557B2 true AU2020396557B2 (en) | 2026-05-14 |
Family
ID=76221229
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2020396557A Active AU2020396557B2 (en) | 2019-12-05 | 2020-12-04 | Protein-loaded PLGA nanospheres |
Country Status (11)
| Country | Link |
|---|---|
| US (3) | US12214046B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4072536A4 (cg-RX-API-DMAC7.html) |
| JP (2) | JP7818514B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR20220143811A (cg-RX-API-DMAC7.html) |
| CN (1) | CN115335041A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2020396557B2 (cg-RX-API-DMAC7.html) |
| BR (1) | BR112022010952A2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3160922A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL293607A (cg-RX-API-DMAC7.html) |
| MX (1) | MX2022006824A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2021113638A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX2022006824A (es) | 2019-12-05 | 2022-09-19 | Univ West Virginia | Nanoesferas de plga cargadas con proteinas. |
| CN116855571B (zh) * | 2023-06-26 | 2025-03-21 | 中国农业大学 | Plga纳米球病毒示踪剂及其制备方法与应用 |
| KR20250069077A (ko) * | 2023-11-10 | 2025-05-19 | 아주대학교산학협력단 | 패티케이션 기술을 적용한 쿠에티아핀-지방산 접합체 나노입자 및 이의 장기 지속형 주사제 용도 |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20180200196A1 (en) * | 2013-11-01 | 2018-07-19 | Yale University | Modular Particulars for Immunotherapy |
Family Cites Families (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6406719B1 (en) | 1998-05-13 | 2002-06-18 | Microbiological Research Authority | Encapsulation of bioactive agents |
| FR2793684B1 (fr) | 1999-05-17 | 2001-08-10 | Ethypharm Lab Prod Ethiques | Utilisation de microspheres biodegradables liberant un agent anticancereux pour le traitement du glioblastome, procede de preparation de ces microspheres et suspension les contenant |
| US20040003402A1 (en) | 2002-06-27 | 2004-01-01 | Digeo, Inc. | Method and apparatus for automatic ticker generation based on implicit or explicit profiling |
| US6974862B2 (en) | 2003-06-20 | 2005-12-13 | Kensey Nash Corporation | High density fibrous polymers suitable for implant |
| WO2005023293A1 (en) * | 2003-09-09 | 2005-03-17 | Pohang University Of Science And Technology | Vaccine composition comprising il-12 adjuvant encapsulated in controlled-release microsphere |
| KR100622996B1 (ko) * | 2005-03-03 | 2006-09-14 | 한국과학기술원 | 약물이 봉입된 비다공성 고분자 미립 담체 및 이의 제조방법 |
| EP1985309B1 (en) | 2005-12-26 | 2016-11-23 | LTT Bio-Pharma Co., Ltd. | Nanoparticles containing water-soluble non-peptide low-molecular weight drug |
| US10265407B2 (en) | 2007-02-15 | 2019-04-23 | Yale University | Modular nanodevices for smart adaptable vaccines |
| DK2251006T3 (en) | 2008-02-22 | 2017-10-16 | Toray Industries | Microparticles and pharmaceutical compositions thereof |
| US9972047B1 (en) | 2008-04-18 | 2018-05-15 | Capital One Services, Llc | Systems and methods for performing a purchase transaction using rewards points |
| US20090281888A1 (en) | 2008-05-09 | 2009-11-12 | Li-Cheng Richard Zai | Method And Apparatus For Establishing Time-Based Loyalty Relationship |
| AU2009268923B2 (en) | 2008-06-16 | 2015-09-17 | Pfizer Inc. | Drug loaded polymeric nanoparticles and methods of making and using same |
| MX2011005672A (es) * | 2008-11-28 | 2011-06-20 | Abbott Lab | Composiciones de anticuerpo estables y metodos para estabilizar a las mismas. |
| WO2011063177A1 (en) | 2009-11-20 | 2011-05-26 | Mobisave Corporation | System and method of electronically verifying required proof-of-performance to secure promotional rewards |
| US8207290B2 (en) | 2010-03-26 | 2012-06-26 | Cerulean Pharma Inc. | Methods and systems for generating nanoparticles |
| WO2012051220A1 (en) * | 2010-10-11 | 2012-04-19 | Wichita State University | Composite magnetic nanoparticle drug delivery system |
| RU2014112958A (ru) * | 2011-09-21 | 2015-10-27 | Йиссум Ресерч Девелопмент Компани оф де Хебрю Юниверсити оф Джерусалем Лтд. | Наносистемы доставки для мирнк |
| US9562015B2 (en) * | 2011-11-17 | 2017-02-07 | The Regents Of The University Of Colorado, A Body | Methods and compositions for enhanced drug delivery to the eye and extended delivery formulations |
| US9610250B2 (en) * | 2012-04-12 | 2017-04-04 | Yale University | Nanolipogel vehicles for controlled delivery of different pharmaceutical agents |
| US10555911B2 (en) | 2012-05-04 | 2020-02-11 | Yale University | Highly penetrative nanocarriers for treatment of CNS disease |
| US9724304B2 (en) | 2012-06-14 | 2017-08-08 | Temple University—Of the Commonwealth System of Higher Education | Nanospheres for therapeutic agent delivery |
| US9308172B2 (en) | 2012-10-26 | 2016-04-12 | Board Of Trustees Of Michigan State University | Device and method for encapsulation of hydrophilic materials |
| US10272050B2 (en) * | 2014-10-14 | 2019-04-30 | The Brigham And Women's Hospital, Inc. | Nanoparticles and methods of use |
| CN104622795B (zh) * | 2015-01-28 | 2017-12-08 | 杭州市萧山区中医院 | 一种多细胞因子序贯缓释微球‑水凝胶复合系统及其制备方法 |
| AU2016251687C1 (en) | 2015-04-22 | 2023-07-27 | CureVac SE | RNA containing composition for treatment of tumor diseases |
| US20170056327A1 (en) * | 2015-08-25 | 2017-03-02 | The Methodist Hospital | Micro/nano composite drug delivery formulations and uses thereof |
| KR102717886B1 (ko) * | 2018-02-26 | 2024-10-16 | 이슘 리서치 디벨롭먼트 컴퍼니 오브 더 히브루 유니버시티 오브 예루살렘 엘티디. | 약물 전달 시스템 |
| CA3141275A1 (en) | 2019-06-18 | 2020-12-24 | Biomeme, Inc. | Systems for sample analysis |
| MX2022006824A (es) | 2019-12-05 | 2022-09-19 | Univ West Virginia | Nanoesferas de plga cargadas con proteinas. |
-
2020
- 2020-12-04 MX MX2022006824A patent/MX2022006824A/es unknown
- 2020-12-04 KR KR1020227022928A patent/KR20220143811A/ko active Pending
- 2020-12-04 BR BR112022010952A patent/BR112022010952A2/pt unknown
- 2020-12-04 IL IL293607A patent/IL293607A/en unknown
- 2020-12-04 CA CA3160922A patent/CA3160922A1/en active Pending
- 2020-12-04 JP JP2022534255A patent/JP7818514B2/ja active Active
- 2020-12-04 EP EP20896361.1A patent/EP4072536A4/en active Pending
- 2020-12-04 WO PCT/US2020/063314 patent/WO2021113638A1/en not_active Ceased
- 2020-12-04 AU AU2020396557A patent/AU2020396557B2/en active Active
- 2020-12-04 CN CN202080095857.XA patent/CN115335041A/zh active Pending
-
2022
- 2022-06-02 US US17/830,615 patent/US12214046B2/en active Active
-
2024
- 2024-11-13 US US18/946,447 patent/US20250064949A1/en active Pending
- 2024-11-19 US US18/952,404 patent/US20250073343A1/en active Pending
-
2026
- 2026-02-09 JP JP2026019595A patent/JP2026077709A/ja active Pending
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20180200196A1 (en) * | 2013-11-01 | 2018-07-19 | Yale University | Modular Particulars for Immunotherapy |
Non-Patent Citations (2)
| Title |
|---|
| Lina Zeng et al. "Poly(lactic-co-glycolic acid) nanoparticle-mediated interleukin-12 delivery for the treatment of diabetic retinopathy." International Journal of Nanomedicine, Vol. 14, 2019, pages 6357-6369. (Year: 2019) * |
| Muhammad Iqbal, Nadiah Zafar, Hatem Fessi, Abdelhamid Elaissari. "Double emulsion solvent evaporation techniques used for drug encapsulation." International Journal of Pharmaceutics, Vol. 496, 2015, pages 173-190. (Year: 2015) * |
Also Published As
| Publication number | Publication date |
|---|---|
| US20250064949A1 (en) | 2025-02-27 |
| CN115335041A (zh) | 2022-11-11 |
| MX2022006824A (es) | 2022-09-19 |
| EP4072536A1 (en) | 2022-10-19 |
| EP4072536A4 (en) | 2025-01-15 |
| WO2021113638A1 (en) | 2021-06-10 |
| BR112022010952A2 (pt) | 2022-09-06 |
| JP2026077709A (ja) | 2026-05-13 |
| AU2020396557A1 (en) | 2022-06-23 |
| US20250073343A1 (en) | 2025-03-06 |
| US12214046B2 (en) | 2025-02-04 |
| JP2023504282A (ja) | 2023-02-02 |
| JP7818514B2 (ja) | 2026-02-20 |
| US20230070180A1 (en) | 2023-03-09 |
| IL293607A (en) | 2022-08-01 |
| CA3160922A1 (en) | 2021-06-10 |
| KR20220143811A (ko) | 2022-10-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20250073343A1 (en) | Protein-loaded plga nanospheres | |
| JP6887685B2 (ja) | ナノ粒子の細胞表面共役 | |
| Xu et al. | Prevention of colorectal cancer liver metastasis by exploiting liver immunity via chitosan-TPP/nanoparticles formulated with IL-12 | |
| US10987314B2 (en) | Antigen-specific, tolerance-inducing microparticles and uses thereof | |
| US6193970B1 (en) | Controlled release of pharmaceutically active substances for immunotherapy | |
| JP5579586B2 (ja) | 腫瘍ワクチン | |
| CN112569207A (zh) | 一种载脂蛋白修饰的仿生纳米肿瘤疫苗及其制备方法和用途 | |
| Jahan et al. | Design and immunological evaluation of anti-CD205-tailored PLGA-based nanoparticulate cancer vaccine | |
| KR101591927B1 (ko) | 고분자 나노입자 기반의 암 백신 조성물 | |
| Lacinski et al. | Synthesis, characterization, and in vivo cytokinome profile of IL‐12‐loaded PLGA nanospheres | |
| JP2023504282A5 (cg-RX-API-DMAC7.html) | ||
| HK40083735A (en) | Protein-loaded plga nanospheres | |
| Markel et al. | Nanocapsule delivery of IL-12 | |
| JP4688254B2 (ja) | 腫瘍ワクチン | |
| EP2925297B1 (en) | Composition comprising cytokine macro-aggregates | |
| CN118436806A (zh) | 一种基于PLGA的OVA-aPD1纳米/微米球混合制剂及其制备方法和应用 | |
| Xu et al. | Enhancement of intranasal mucosal immunization of mucosal vaccines by ultrasonic treatment | |
| KR102912021B1 (ko) | 광민감제와 면역증강제를 포함하는 광면역 치료용 나노입자 및 이의 용도 | |
| CN116115565B (zh) | 一种plga纳米乳及其制备和在副结核疫苗中的应用 | |
| US20250134961A1 (en) | Oral formulation for activation of autologous stem cells | |
| CN119185522A (zh) | 一种载细菌全抗原的plga微球疫苗及其制备方法与应用 |